Tyra Biosciences, Inc.
TYRA
$10.04
-$0.05-0.50%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.57M | -24.02M | -18.70M | -18.19M | -22.83M |
| Total Depreciation and Amortization | 144.00K | 127.00K | 126.00K | 122.00K | 102.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.52M | 5.97M | 2.54M | 2.89M | 2.94M |
| Change in Net Operating Assets | 318.00K | 23.00K | 5.77M | -6.84M | 6.26M |
| Cash from Operations | -19.59M | -17.90M | -10.26M | -22.03M | -13.53M |
| Capital Expenditure | -6.00K | -52.00K | -470.00K | -136.00K | -603.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.96M | 21.61M | -144.52M | 18.21M | -143.84M |
| Cash from Investing | 6.96M | 21.56M | -144.99M | 18.07M | -144.44M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 706.00K | 743.00K | 624.00K | 200.48M | 324.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 0.00 | -251.00K | -169.00K | -- |
| Cash from Financing | 706.00K | 743.00K | 373.00K | 200.32M | 324.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.93M | 4.40M | -154.88M | 196.36M | -157.65M |